English

ACHILLION PHARMACEUTICALS INC

EDGAR

ACHN Quarterly report (10-Q) · filed 2019-11-07

119 filing records in this dataset, filed from 2006-11-17 to 2019-11-07. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2019 Q2 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Operating cash flow

-14.1 million USD

2019 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -31803000 USD Source
Operating Cash Flow: -17727000 USD Source

Cash and cash equivalents: 43.6 million USD 2019-09-30 Source
Exact value

43567000 USD
Long-term debt including current maturities: 652 thousand USD 2016-12-31 Source
Exact value

652000 USD
Shares outstanding: 140 million shares 2019-09-30 Source
Exact value

139891000 shares

Reported share-count change

0.94% · 1.3 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

138589000 shares · 2018-09-30· Source
139891000 shares · 2019-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Capital expenditure

155 thousand USD

2009-07-01 – 2010-06-30

Exact inputs and evidence

Capital expenditure: 42000 USD · 2009-01-01 – 2009-09-30 Source
Capital expenditure: 42000 USD · 2009-01-01 – 2009-06-30 Source
Capital expenditure: 42000 USD · 2009-01-01 – 2009-12-31 Source
Capital expenditure: 42000 USD · 2009-01-01 – 2009-09-30 Source
Capital expenditure: 18000 USD · 2010-01-01 – 2010-03-31 Source
Capital expenditure: 155000 USD · 2010-01-01 – 2010-06-30 Source
Capital expenditure: 18000 USD · 2010-01-01 – 2010-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2019-11-07.

Financial data available through: 2018-12-31.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2016-12-31
Operating income: 10 of 11 periods available· newest 2018-12-31
Net income: 10 of 11 periods available· newest 2018-12-31
Operating cash flow: 10 of 11 periods available· newest 2018-12-31
Capital expenditure: 2 of 11 periods available· newest 2009-12-31
Total assets: 10 of 11 periods available· newest 2018-12-31
Total liabilities: 10 of 11 periods available· newest 2018-12-31
Current assets: 10 of 11 periods available· newest 2018-12-31
Current liabilities: 10 of 11 periods available· newest 2018-12-31
Cash and cash equivalents: 10 of 11 periods available· newest 2018-12-31
Long-term debt including current maturities: 6 of 11 periods available· newest 2016-12-31
Shares outstanding: 8 of 11 periods available· newest 2018-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
+USD 14.96 million

Prior period

−USD 85.24 million

2017-01-01 – 2017-12-31
Current period

−USD 70.27 million

2018-01-01 – 2018-12-31

Exact inputs and evidence

-70272000 − -85236000 = 14964000 USD

-85236000 USD · 2017-01-01 – 2017-12-31
Inspect prior input Prior source
-70272000 USD · 2018-01-01 – 2018-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · ACHILLION PHARMACEUTICALS INC · 2018-12-31 ACHILLION PHARMACEUTICALS INC (edgar:1070336) Year-over-year change in Net income: 14964000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070336?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -70272000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070336/000119312519067172/achn-20181231.xml#203998 Filing: 000119312519067172 Input fundies:NetIncome: -85236000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070336/000119312519067172/achn-20181231.xml#111222 Filing: 000119312519067172
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 2.53 million

Prior period

−USD 59.48 million

2017-01-01 – 2017-12-31
Current period

−USD 62.01 million

2018-01-01 – 2018-12-31

Exact inputs and evidence

-62012000 − -59478000 = -2534000 USD

-59478000 USD · 2017-01-01 – 2017-12-31
Inspect prior input Prior source
-62012000 USD · 2018-01-01 – 2018-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · ACHILLION PHARMACEUTICALS INC · 2018-12-31 ACHILLION PHARMACEUTICALS INC (edgar:1070336) Year-over-year change in Operating cash flow: -2534000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070336?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -62012000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070336/000119312519067172/achn-20181231.xml#111516 Filing: 000119312519067172 Input fundies:OperatingCashFlow: -59478000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070336/000119312519067172/achn-20181231.xml#111721 Filing: 000119312519067172
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2016 2016-01-01 – 2016-12-31

Revenue USD 15 million 100% of revenue
Operating costs Derived USD 79.87 million 532% of revenue
Operating income −USD 64.87 million −432% of revenue
Tax, interest and other Derived −USD 3.16 million −21% of revenue
Net income −USD 61.71 million −411% of revenue

Cash

Operating cash flow −USD 65.65 million −438% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2008 Not shown: operating income or net income is not reported.
2010 Operating loss: operating costs were 1,139% of revenue.
2011 Operating loss: operating costs were 18,054% of revenue.
2012 Operating loss: operating costs were 1,914% of revenue.
2015 Operating loss: operating costs were 123% of revenue.
2016 Operating loss: operating costs were 532% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2008 2008-01-01 – 2008-12-31	-234000	27564000 Derived	-27798000	353000 Derived	-28151000	-24987000 Derived	Source 2008-01-01 – 2008-12-31: -234000 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -27798000 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: -28151000 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: -24910000 USD Inspect Operating Cash Flow Open source 2008-01-01 – 2008-12-31: 77000 USD Inspect Capital Expenditure Open source
2010 2010-01-01 – 2010-12-31	2436000	27734000 Derived	-25298000	183000 Derived	-25481000	Unavailable	Source 2010-01-01 – 2010-12-31: 2436000 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: -25298000 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: -25481000 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: -24297000 USD Inspect Operating Cash Flow Open source
2011 2011-01-01 – 2011-12-31	247000	44594000 Derived	-44347000	-141000 Derived	-44206000	Unavailable	Source 2011-01-01 – 2011-12-31: 247000 USD Inspect Revenue Open source 2011-01-01 – 2011-12-31: -44347000 USD Inspect Operating Income Open source 2011-01-01 – 2011-12-31: -44206000 USD Inspect Net Income Open source 2011-01-01 – 2011-12-31: -36136000 USD Inspect Operating Cash Flow Open source
2012 2012-01-01 – 2012-12-31	2607000	49900000 Derived	-47293000	-166000 Derived	-47127000	Unavailable	Source 2012-01-01 – 2012-12-31: 2607000 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: -47293000 USD Inspect Operating Income Open source 2012-01-01 – 2012-12-31: -47127000 USD Inspect Net Income Open source 2012-01-01 – 2012-12-31: -46534000 USD Inspect Operating Cash Flow Open source
2015 2015-01-01 – 2015-12-31	66122000	81229000 Derived	-15107000	-10077000 Derived	-5030000	Unavailable	Source 2015-01-01 – 2015-12-31: 66122000 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: -15107000 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -5030000 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: 5577000 USD Inspect Operating Cash Flow Open source
2016 2016-01-01 – 2016-12-31	15000000	79865000 Derived	-64865000	-3159000 Derived	-61706000	Unavailable	Source 2016-01-01 – 2016-12-31: 15000000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -64865000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -61706000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -65653000 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 15M 2016

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-12-31	Revenue	-234000	Revenue: -234000 Open source
20102010-12-31	Revenue	2436000	Revenue: 2436000 Open source
20112011-12-31	Revenue	247000	Revenue: 247000 Open source
20122012-12-31	Revenue	2607000	Revenue: 2607000 Open source
20152015-12-31	Revenue	66122000	Revenue: 66122000 Open source
20162016-12-31	Revenue	15000000	Revenue: 15000000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-77.3% 2016

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20082008-12-31	Year over year	No prior comparable period	Revenue: -234000 Open source
20102010-12-31	Year over year	No prior comparable period	Revenue: 2436000 Open source
20112011-12-31	Year over year	-89.9%	Revenue: 247000 Open source Revenue: 2436000 Open source
20122012-12-31	Year over year	955.5%	Revenue: 2607000 Open source Revenue: 247000 Open source
20152015-12-31	Year over year	No prior comparable period	Revenue: 66122000 Open source
20162016-12-31	Year over year	-77.3%	Revenue: 15000000 Open source Revenue: 66122000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -432.4% 2016

Net margin -411.4% 2016

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20082008-12-31	Operating margin	11,879.5%	Operating Income: -27798000 Open source Revenue: -234000 Open source
20102010-12-31	Operating margin	-1,038.5%	Operating Income: -25298000 Open source Revenue: 2436000 Open source
20112011-12-31	Operating margin	-17,954.3%	Operating Income: -44347000 Open source Revenue: 247000 Open source
20122012-12-31	Operating margin	-1,814.1%	Operating Income: -47293000 Open source Revenue: 2607000 Open source
20152015-12-31	Operating margin	-22.8%	Operating Income: -15107000 Open source Revenue: 66122000 Open source
20162016-12-31	Operating margin	-432.4%	Operating Income: -64865000 Open source Revenue: 15000000 Open source
20082008-12-31	Net margin	12,030.3%	Net Income: -28151000 Open source Revenue: -234000 Open source
20102010-12-31	Net margin	-1,046%	Net Income: -25481000 Open source Revenue: 2436000 Open source
20112011-12-31	Net margin	-17,897.2%	Net Income: -44206000 Open source Revenue: 247000 Open source
20122012-12-31	Net margin	-1,807.7%	Net Income: -47127000 Open source Revenue: 2607000 Open source
20152015-12-31	Net margin	-7.6%	Net Income: -5030000 Open source Revenue: 66122000 Open source
20162016-12-31	Net margin	-411.4%	Net Income: -61706000 Open source Revenue: 15000000 Open source
20082008-12-31	Free cash flow margin	Not reported	Revenue: -234000 Open source
20102010-12-31	Free cash flow margin	Not reported	Revenue: 2436000 Open source Operating Cash Flow: -24297000 Open source
20112011-12-31	Free cash flow margin	Not reported	Revenue: 247000 Open source Operating Cash Flow: -36136000 Open source
20122012-12-31	Free cash flow margin	Not reported	Revenue: 2607000 Open source Operating Cash Flow: -46534000 Open source
20152015-12-31	Free cash flow margin	Not reported	Revenue: 66122000 Open source Operating Cash Flow: 5577000 Open source
20162016-12-31	Free cash flow margin	Not reported	Revenue: 15000000 Open source Operating Cash Flow: -65653000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -65.7M 2016

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-12-31	Operating cash flow	Not reported	No source recorded
20102010-12-31	Operating cash flow	-24297000	Operating Cash Flow: -24297000 Open source
20112011-12-31	Operating cash flow	-36136000	Operating Cash Flow: -36136000 Open source
20122012-12-31	Operating cash flow	-46534000	Operating Cash Flow: -46534000 Open source
20152015-12-31	Operating cash flow	5577000	Operating Cash Flow: 5577000 Open source
20162016-12-31	Operating cash flow	-65653000	Operating Cash Flow: -65653000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-12-31	Free cash flow	Unavailable	No source recorded
20102010-12-31	Free cash flow	Unavailable	Operating Cash Flow: -24297000 Open source
20112011-12-31	Free cash flow	Unavailable	Operating Cash Flow: -36136000 Open source
20122012-12-31	Free cash flow	Unavailable	Operating Cash Flow: -46534000 Open source
20152015-12-31	Free cash flow	Unavailable	Operating Cash Flow: 5577000 Open source
20162016-12-31	Free cash flow	Unavailable	Operating Cash Flow: -65653000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

3.5% 2016

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20082008-12-31	Liabilities / assets	35.1%	Total Liabilities: 13540000 Open source Total Assets: 38561000 Open source
2010-12-31	Liabilities / assets	Not reported	No source recorded
20112011-12-31	Liabilities / assets	14.1%	Total Liabilities: 11662000 Open source Total Assets: 82630000 Open source
20122012-12-31	Liabilities / assets	11.6%	Total Liabilities: 9483000 Open source Total Assets: 81530000 Open source
20152015-12-31	Liabilities / assets	3.2%	Total Liabilities: 14889000 Open source Total Assets: 464525000 Open source
20162016-12-31	Liabilities / assets	3.5%	Total Liabilities: 14421000 Open source Total Assets: 413875000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

27.38× 2016

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20082008-12-31	Current assets / current liabilities	3×	Current Assets: 36538000 Open source Current Liabilities: 12179000 Open source
2010-12-31	Current assets / current liabilities	Not reported	No source recorded
20112011-12-31	Current assets / current liabilities	6.16×	Current Assets: 55092000 Open source Current Liabilities: 8944000 Open source
20122012-12-31	Current assets / current liabilities	7.43×	Current Assets: 67867000 Open source Current Liabilities: 9136000 Open source
20152015-12-31	Current assets / current liabilities	31.56×	Current Assets: 462588000 Open source Current Liabilities: 14658000 Open source
20162016-12-31	Current assets / current liabilities	27.38×	Current Assets: 382535000 Open source Current Liabilities: 13971000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2009 2009-01-01 – 2009-12-31	Unavailable Not reported for this period.	Unavailable Not reported for this period.	USD 42,000 Exact value Exact value: 42000 USD 2009-01-01 – 2009-12-31: 42000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ACHILLION PHARMACEUTICALS INC · 2009-12-31 ACHILLION PHARMACEUTICALS INC (edgar:1070336) Capital Expenditure: 42000 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070336/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 42000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070336/0001193125-10-053956.txt#8038 The citation records this snapshot. The page link may show a newer release later.	Unavailable Free cash flow cannot be calculated because Operating cash flow is unavailable for this period.
2010 2010-01-01 – 2010-12-31	−USD 25.48 million Exact value Exact value: -25481000 USD 2010-01-01 – 2010-12-31: -25481000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ACHILLION PHARMACEUTICALS INC · 2010-12-31 ACHILLION PHARMACEUTICALS INC (edgar:1070336) Net Income: -25481000 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070336/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -25481000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070336/000119312513067169/achn-20121231.xml#98996 Filing: 000119312513067169 The citation records this snapshot. The page link may show a newer release later.	−USD 24.3 million Exact value Exact value: -24297000 USD 2010-01-01 – 2010-12-31: -24297000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ACHILLION PHARMACEUTICALS INC · 2010-12-31 ACHILLION PHARMACEUTICALS INC (edgar:1070336) Operating Cash Flow: -24297000 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070336/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -24297000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070336/000119312513067169/achn-20121231.xml#91297 Filing: 000119312513067169 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2011 2011-01-01 – 2011-12-31	−USD 44.21 million Exact value Exact value: -44206000 USD 2011-01-01 – 2011-12-31: -44206000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ACHILLION PHARMACEUTICALS INC · 2011-12-31 ACHILLION PHARMACEUTICALS INC (edgar:1070336) Net Income: -44206000 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070336/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -44206000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070336/000119312514089075/achn-20131231.xml#88205 Filing: 000119312514089075 The citation records this snapshot. The page link may show a newer release later.	−USD 36.14 million Exact value Exact value: -36136000 USD 2011-01-01 – 2011-12-31: -36136000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ACHILLION PHARMACEUTICALS INC · 2011-12-31 ACHILLION PHARMACEUTICALS INC (edgar:1070336) Operating Cash Flow: -36136000 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070336/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -36136000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070336/000119312514089075/achn-20131231.xml#82664 Filing: 000119312514089075 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2012 2012-01-01 – 2012-12-31	−USD 47.13 million Exact value Exact value: -47127000 USD 2012-01-01 – 2012-12-31: -47127000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ACHILLION PHARMACEUTICALS INC · 2012-12-31 ACHILLION PHARMACEUTICALS INC (edgar:1070336) Net Income: -47127000 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070336/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -47127000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070336/000119312515078840/achn-20141231.xml#805750 Filing: 000119312515078840 The citation records this snapshot. The page link may show a newer release later.	−USD 46.53 million Exact value Exact value: -46534000 USD 2012-01-01 – 2012-12-31: -46534000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ACHILLION PHARMACEUTICALS INC · 2012-12-31 ACHILLION PHARMACEUTICALS INC (edgar:1070336) Operating Cash Flow: -46534000 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070336/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -46534000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070336/000119312515078840/achn-20141231.xml#797633 Filing: 000119312515078840 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2013 2013-01-01 – 2013-12-31	−USD 58.95 million Exact value Exact value: -58947000 USD 2013-01-01 – 2013-12-31: -58947000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ACHILLION PHARMACEUTICALS INC · 2013-12-31 ACHILLION PHARMACEUTICALS INC (edgar:1070336) Net Income: -58947000 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070336/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -58947000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070336/000119312516478314/achn-20151231.xml#97834 Filing: 000119312516478314 The citation records this snapshot. The page link may show a newer release later.	−USD 53.64 million Exact value Exact value: -53636000 USD 2013-01-01 – 2013-12-31: -53636000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ACHILLION PHARMACEUTICALS INC · 2013-12-31 ACHILLION PHARMACEUTICALS INC (edgar:1070336) Operating Cash Flow: -53636000 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070336/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -53636000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070336/000119312516478314/achn-20151231.xml#92152 Filing: 000119312516478314 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2014 2014-01-01 – 2014-12-31	−USD 69.01 million Exact value Exact value: -69008000 USD 2014-01-01 – 2014-12-31: -69008000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ACHILLION PHARMACEUTICALS INC · 2014-12-31 ACHILLION PHARMACEUTICALS INC (edgar:1070336) Net Income: -69008000 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070336/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -69008000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070336/000119312517054009/achn-20161231.xml#97372 Filing: 000119312517054009 The citation records this snapshot. The page link may show a newer release later.	−USD 55.52 million Exact value Exact value: -55524000 USD 2014-01-01 – 2014-12-31: -55524000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ACHILLION PHARMACEUTICALS INC · 2014-12-31 ACHILLION PHARMACEUTICALS INC (edgar:1070336) Operating Cash Flow: -55524000 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070336/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -55524000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070336/000119312517054009/achn-20161231.xml#92820 Filing: 000119312517054009 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2015 2015-01-01 – 2015-12-31	−USD 5.03 million Exact value Exact value: -5030000 USD 2015-01-01 – 2015-12-31: -5030000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ACHILLION PHARMACEUTICALS INC · 2015-12-31 ACHILLION PHARMACEUTICALS INC (edgar:1070336) Net Income: -5030000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070336/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5030000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070336/000119312518052951/achn-20171231.xml#88115 Filing: 000119312518052951 The citation records this snapshot. The page link may show a newer release later.	USD 5.58 million Exact value Exact value: 5577000 USD 2015-01-01 – 2015-12-31: 5577000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ACHILLION PHARMACEUTICALS INC · 2015-12-31 ACHILLION PHARMACEUTICALS INC (edgar:1070336) Operating Cash Flow: 5577000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070336/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 5577000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070336/000119312518052951/achn-20171231.xml#82839 Filing: 000119312518052951 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2016 2016-01-01 – 2016-12-31	−USD 61.71 million Exact value Exact value: -61706000 USD 2016-01-01 – 2016-12-31: -61706000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ACHILLION PHARMACEUTICALS INC · 2016-12-31 ACHILLION PHARMACEUTICALS INC (edgar:1070336) Net Income: -61706000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070336/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -61706000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070336/000119312519067172/achn-20181231.xml#111369 Filing: 000119312519067172 The citation records this snapshot. The page link may show a newer release later.	−USD 65.65 million Exact value Exact value: -65653000 USD 2016-01-01 – 2016-12-31: -65653000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ACHILLION PHARMACEUTICALS INC · 2016-12-31 ACHILLION PHARMACEUTICALS INC (edgar:1070336) Operating Cash Flow: -65653000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070336/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -65653000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070336/000119312519067172/achn-20181231.xml#111926 Filing: 000119312519067172 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2017 2017-01-01 – 2017-12-31	−USD 85.24 million Exact value Exact value: -85236000 USD 2017-01-01 – 2017-12-31: -85236000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ACHILLION PHARMACEUTICALS INC · 2017-12-31 ACHILLION PHARMACEUTICALS INC (edgar:1070336) Net Income: -85236000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070336/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -85236000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070336/000119312519067172/achn-20181231.xml#111222 Filing: 000119312519067172 The citation records this snapshot. The page link may show a newer release later.	−USD 59.48 million Exact value Exact value: -59478000 USD 2017-01-01 – 2017-12-31: -59478000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ACHILLION PHARMACEUTICALS INC · 2017-12-31 ACHILLION PHARMACEUTICALS INC (edgar:1070336) Operating Cash Flow: -59478000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070336/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -59478000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070336/000119312519067172/achn-20181231.xml#111721 Filing: 000119312519067172 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2018 2018-01-01 – 2018-12-31	−USD 70.27 million Exact value Exact value: -70272000 USD 2018-01-01 – 2018-12-31: -70272000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ACHILLION PHARMACEUTICALS INC · 2018-12-31 ACHILLION PHARMACEUTICALS INC (edgar:1070336) Net Income: -70272000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070336/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -70272000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070336/000119312519067172/achn-20181231.xml#203998 Filing: 000119312519067172 The citation records this snapshot. The page link may show a newer release later.	−USD 62.01 million Exact value Exact value: -62012000 USD 2018-01-01 – 2018-12-31: -62012000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ACHILLION PHARMACEUTICALS INC · 2018-12-31 ACHILLION PHARMACEUTICALS INC (edgar:1070336) Operating Cash Flow: -62012000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070336/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -62012000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070336/000119312519067172/achn-20181231.xml#111516 Filing: 000119312519067172 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

119 filings · 2,347 latest values · 2,347 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001070336, 1070336, ACHN, edgar:1070336

Also known as ACHILLION PHARMACEUTICALS INC

ACHILLION PHARMACEUTICALS INC

Latest quarter

Revenue

Operating cash flow

Reported share-count change

Trailing twelve months

Capital expenditure

Company performance

What changed year over year

Net income

Operating cash flow

Where revenue goes

2016 2016-01-01 – 2016-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation